Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sethi, K. D.
Right arrow Articles by Adams, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sethi, K. D.
Right arrow Articles by Adams, R. J.
NEUROLOGY 1992;42:919
© 1992 American Academy of Neurology

Acetazolamide treatment of paroxysmal dystonia in central demyelinating disease

Kapil D. Sethi, MD, MRCP(UK), David C. Hess, MD, Vera H. Huffnagle, MD and Robert J. Adams, MD

Department of Neurology. Medical College of Georgia. Augusta, GA.

We report successful treatment of paroxysmal dystonia (tonic seizures) in three patients with central demyelinating disease (CDD) using acetazolamide alone or in combination with carbamazepine. Acetazolamide is a useful alternative, or an adjunct, to carbamazepine in the treatment of paroxysmal dystonia in CDD.

Address correspondence and reprint requests to Dr. Kapil D. Sethi, Department of Neurology, Medical College of Georgia. 1120 15th Street, Augusta, GA 30912.

Presented in part at the Hyperkinetic Movement Disorder symposium held in conjunction with the American Neurological Association meeting, Atlanta, GA, October. 1990.

Received July 3, 1991. Accepted for publication in final form September 16. 1991.




This article has been cited by other articles:


Home page
 NeurologyHome page
J. C. Morgan, M. Hughes, R. E. Figueroa, and K. D. Sethi
Psychogenic paroxysmal dyskinesia following paroxysmal hemidystonia in multiple sclerosis
Neurology, September 27, 2005; 65(6): E12 - E12.
[Full Text] [PDF]

Home page
 NeurologyHome page
J. C. Morgan, D. C. Hess, K. D. Sethi, D. A. Restivo, M. Tinazzi, F. Patti, A. Palmeri, and D. Maimone
Botulinum toxin treatment of painful tonic spasms in multiple sclerosis
Neurology, June 8, 2004; 62(11): 2143 - 2143.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.